Source: Annual Congress 2011 - COPD: human studies
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Caramori, P. Casolari, E. Garofano, M. Contoli, G. Gnesini, A. Padovani, K. F. Chung, P. J. Barnes, I. M. Adcock, A. Papi (Ferrara, Italy; London, United Kingdom). Expression of the phosphorylated myristoylated alanine-rich C kinase substrate (MARCKS) in COPD bronchial glands. Eur Respir J 2011; 38: Suppl. 55, 728

Member's Comments

No comment yet.

Related content which might interest you: Increased phosphorylated p38 mitogen-activated protein kinase in COPD lungs Source: Eur Respir J 2013; 42: 28-41 Year: 2013 Inhibition of p38 MAPK-dependent bronchial contraction after ozone by corticosteroids Source: Eur Respir J 2011; 37: 933-942 Year: 2011 Mice deficient in Raf kinase inhibitor protein (RKIP) have elevated indices of pulmonary hypertension Source: Annual Congress 2010 - Experimental pulmonary hypertension Year: 2010 FIZZ1 potentiates the carbachol-induced tracheal smooth muscle contraction Source: Eur Respir J 2010; 36: 1165-1173 Year: 2010 Expression of phosphorylated p38 MAPK in the lung of smokers with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 582s Year: 2006 Mitogen activated protein kinase activated protein kinase 2 regulates actin stress fiber formation in ventilator associated lung injury Source: Annual Congress 2008 - Pulmonary vascular biology Year: 2008 Roflumilast N-oxide (RNO) increases MAP kinase phosphatase-1 (MKP-1) expression in human lung fibroblasts (HLF) Source: Annual Congress 2010 - Lung cell biology and immunology Year: 2010 Effect of fudosteine on mucin production Source: Eur Respir J 2008; 32: 1195-1202 Year: 2008 LATE-BREAKING ABSTRACT: Evaluation of an oral p38 mitogen activated protein kinase (MAPK inhibitor) SB-681323 in COPD Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009 Expression of discoidin domain receptor 1 tyrosine kinase on the human bronchial epithelium Source: Eur Respir J 2001; 17: 969-974 Year: 2001 The effects of oral p38 mitogen activated protein kinase (MAPK) inhibitor SB-681323 on blood biomarkers in COPD Source: Annual Congress 2008 - Novel treatments for respiratory disease Year: 2008 Validation of AMP-activated protein kinase as a therapeutic target in bronchiectasis Source: ERS Lung Science Conference 2020 Year: 2020 Constitutive phosphorylation of p38 mitogen activated protein kinase controls proliferation of mesothelioma cells Source: Eur Respir J 2005; 26: Suppl. 49, 225s Year: 2005 Role of c-Jun N-terminal kinase in human eosinophil apoptosis Source: Eur Respir J 2004; 24: Suppl. 48, 36s Year: 2004 Phosphorylation of xanthine dehydrogenase/oxidase in hypoxia: role of p38 MAP kinase Source: Eur Respir J 2001; 18: Suppl. 33, 73s Year: 2001 Hemaglutinin (HA) of H5N1 disturbs cAMP-dependent CFTR channel via activation of janus kinase 3 Source: Annual Congress 2009 - Translational models of lung disease Year: 2009 The effect of smoking on phosphoinositide 3-kinase (PI3K) and phosphatase and tensin homolog deleted from chromosome 10 (PTEN) mRNA expression in human airway epithelial cells Source: International Congress 2014 – Mechanistic studies of the airway epithelium Year: 2014 Inhibition of phosphatidylinositol 3-kinase and mitogen-activated protein kinase kinase prevents malignant pleural mesothelioma cell growth Source: Annual Congress 2010 - Basic mechanisms in malignant pleural disease biology Year: 2010